Press "esc" to clear
Go to Advanced Search

Showing results

110 of 885

Article ID: 699160

Mayo Medical Laboratories, National Decision Support Company Team Up to Develop Careselect Blood, a Comprehensive Approach to Patient Blood Management

Mayo Clinic

ROCHESTER, Minn. — Mayo Clinic implemented a patient blood-management program in 2010 on its Rochester campus and has since experienced a 35-percent reduction of blood transfusions, improving patient outcomes and achieving significant savings. Using best practices from the program, Mayo Medical Laboratories, the global reference laboratory of Mayo Clinic, collaborated with National Decision Support Company (NDSC) to combine Mayo’s clinical knowledge with NDSC’s industry-leading expertise in electronic health record (EHR) clinical-decision support.

Released:
17-Aug-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
BiomedicalGraphic.jpg

Article ID: 699086

The Badge Advantage: Skeletal Muscle as an Endocrine Organ

Wichita State University

Wichita State University is offering an online badge course In what may be one of the only classes nationwide teaching practical blood flow restriction, defined as BFR, using low-cost equipment.

Released:
16-Aug-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Education

GettyImages-675680602.jpg

Article ID: 699079

There’s No Place Like Home: Study Finds Patients with Low-Risk Blood Clots May Be Better Off Receiving Treatment at Home

Intermountain Medical Center

New study by researchers at Intermountain Medical Center in Salt Lake City found that patients with low-risk blood clots may be better off receiving treatment at home versus being admitted to the hospital.

Released:
16-Aug-2018 6:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RUNXproteinsasregulatorsforDNArepair_photo.jpg

Article ID: 699008

NUS study: RUNX proteins act as regulators in DNA repair

National University of Singapore

A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) pathway.

Released:
15-Aug-2018 3:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698868

Mount Sinai Receives $4 Million Grant to Study Use of Inhaled Corticosteroids for Sickle Cell Treatment

Mount Sinai Health System

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease (SCD) in individuals who do not have asthma.

Released:
13-Aug-2018 10:45 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
adolescent-large.jpg
  • Embargo expired:
    10-Aug-2018 11:00 AM EDT

Article ID: 698762

Global Funding for Adolescent Health Misses the Target

Harvard Medical School

Adolescents make up more than a quarter of the population in developing countries. Only 1.6 percent of global development assistance for health from 2003-2016 went to adolescent health. Resource allocation failed to address many of the diseases that take the worst toll on adolescent health, such as depressive disorders, anemia and injuries.

Released:
9-Aug-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS21549_AdamWende-MarkPepin-5-scr_edited.jpg

Article ID: 698801

Epigenetic Reprogramming of Human Hearts Found in Congestive Heart Failure

University of Alabama at Birmingham

Researchers have now described an underlying mechanism that reprograms the hearts of patients with ischemic cardiomyopathy, a process that differs from patients with other forms of heart failure. This points the way toward future personalized care.

Released:
9-Aug-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698780

Discovery Could Lead to Better Treatment for Leukemia

University of Illinois at Chicago

Previous research has revealed that patients with acute myeloid leukemia who also have a particular mutation in a gene called NPM1 have a higher rate of remission with chemotherapy. About one-third of leukemia patients possess this favorable mutation, but until now, how it helps improve outcomes has remained unknown.Scientists from the University of Illinois at Chicago report on how this mutation helps improve sensitivity to chemotherapy in patients in the journal JCI Insight.

Released:
9-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698695

First FDA-Approved Study of Focused Ultrasound to Open Blood-Brain Barrier

University of Maryland Medical Center/School of Medicine

In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).

Released:
9-Aug-2018 9:45 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ZhouLu351x234.jpg

Article ID: 698761

An Ancient Medicine Shows New Promise: Arsenic in Combination with an Existing Drug Could Combat Cancer

Beth Israel Deaconess Medical Center

Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator. The team, led by researchers at the Cancer Center at Beth Israel Deaconess Medical Center, is hopeful that the discovery could lead to new treatment strategies for diverse types of cancer.

Released:
9-Aug-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 885





Chat now!